Patient Education
Share your love
Study Links Socioeconomics to Severe Retinal Detachment
A recent study indicates that patients living in socioeconomically deprived neighborhoods are more likely to present with severe rhegmatogenous retinal detachment (RRD), a serious eye condition that can lead to vision loss if not treated promptly. Adverse social determinants of…
AI Retinal Scanning for Cardiovascular Risk Assessment
A collaborative team of international researchers is exploring the potential of artificial intelligence (AI) in ophthalmology to assess cardiovascular risks by analyzing retinal images. The study has been detailed in a position paper published in the Asia-Pacific Journal of Ophthalmology.…
De-escalated Chemo Effective for High-Risk Retinoblastoma
A recent study reveals that a shortened adjuvant chemotherapy regimen offers similar efficacy and improved safety for infants with unilateral pathologic high-risk retinoblastoma. Results showed enhanced five-year disease-free survival (DFS) among infants receiving three cycles of chemotherapy compared to those…
Hidden Visual Deficits in Mild TBI Uncovered
A groundbreaking study led by Vanderbilt University Medical Center has unveiled subtle changes in the visual pathways of individuals with chronic mild traumatic brain injury (TBI). These findings highlight structural and functional deficits, even when standard eye examinations reveal no…
Neuronal Circuit Model Unlocks Eye Movement Insights
A groundbreaking study by researchers at Weill Cornell Medicine and collaborators has unveiled how neuronal circuits in the brainstem guide eye movement, offering potential advancements in the treatment of eye movement disorders. Using week-old zebrafish, the team explored how connections…
UC Irvine Study Links DNA Damage to AMD Progression
A groundbreaking study led by researchers at the University of California, Irvine, has identified accumulated DNA damage in the retina as a critical factor in the development of age-related macular degeneration (AMD). The findings, recently published in Aging Cell, could…
OneSight and WHO Partner on SPECS 2030
The OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health Organization (WHO) as a global collaborator in the SPECS 2030 initiative. This alliance aims to expedite progress toward achieving the first global target for effective refractive error…
Global Myopia Surge in Children Predicted to Hit 740M by 2050
A new analysis published in the British Journal of Ophthalmology reveals that nearly one in three children and teens worldwide is expected to be affected by myopia by 2050, translating to over 740 million cases. This trend reflects a significant…
Cambium Bio Raises Funds for Dry Eye Trials
Cambium Bio Limited, a clinical-stage regenerative medicine company, announced that it has successfully completed an A$3.0 million capital raising round. This funding will primarily support the development of Elate Ocular, a novel treatment for dry eye disease (DED), through registration-enabling…
Galimedix Starts Phase 1 Trial for Oral GAL-101
Galimedix Therapeutics Inc. has announced the initiation of dosing in a Phase 1 clinical trial for oral GAL-101, an innovative amyloid beta (Aβ) aggregation modulator. The study aims to assess the therapy’s safety, tolerability, and pharmacokinetics, marking a significant step…